Bristol-Myers Squibb Company
Substituted imidazo[1,2-b]pyridazines as interleukin-23 and interferon-.alpha. modulators

Last updated:

Abstract:

Compounds of formula (I) or a stereoisomer or pharmaceutically-acceptable salt thereof, are useful in the modulation of IL-12, IL-23 and/or IFN.alpha., by acting on Tyk-2 to cause signal transduction inhibition. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

16 Nov 2017

Issue date:

12 Apr 2022